Allocations
Eurazeo has launched O+, an ESG initiative which the company says will promote the drive towards low carbon and a more inclusive economy, in line with the UN Sustainable Development Goals.
O+ has two main pillars: achieving zero net carbon by 2040 at the latest and playing a role in bridging the widening social gaps.
The aim is to accelerate the transition to a low carbon economy and committing to zero net carbon across the group by 2040, in alignment with the UN’s Science Based Targets initiative.
“As CEO of an investment firm supporting more than 430 companies, I see the benefits
An affiliate of private investment firm Sun Capital Partners (Sun Capital), has made an investment in Mancini’s Sleepworld (Mancini’s” or “the Company”), a mattress retailer serving the Northern California market. Terms of the private transaction have not been disclosed.
Founded by the Mancini family in 1969, Mancini’s Sleepworld sells leading brand mattresses and other sleep products such as adjustable bed frames. Randy Mancini, a second-generation owner, has built the successful business to [approximately][Seems odd to appear not to know the precise number of locations] 33 locations throughout the Bay area.
“Mancini’s is in Sun Capital’s sweet spot: a family-owned business in
Prime Capital, an independent asset manager and financial services provider that manages EUR17.7 billion across multiple funds, together with ENERPARC AG, has arranged the junior debt financing for a European solar PV portfolio, which is owned by the independent power producer MKM Invest Group. The portfolio consists of solar PV projects in Germany, France, and Spain with a total capacity of 579MW. The financing of 106m EUR was provided by accounts managed by Prime Capital. ENERPARC, who has been developing and realising the solar parks for MKM Invest Group, supported the fundraising on behalf of the sponsor and will deliver the
Cornerstone Brands has completed its acquisition of FXPress Payment Services Ltd (FXPress) following consent from the FCA. FXPress, a regulated Authorised Payment Institution providing cross-border payment services, is now a wholly-owned subsidiary of Cornerstone.
Cornerstone is also pleased to announce that it has received the consent of the FCA for the acquisition of Avila House by FXPress.
Completion of the acquisitions means that Cornerstone will bring together the technology capabilities of FXPress, the e-money assets of Avila House and a strong team with decades of experience of the foreign exchange and payments industry to create a leading cloud-based, multi-currency
An affiliate of middle-market private investment firm Peak Rock Capital (Peak Rock), a middle-market private investment firm, has completed its acquisition of Halo Foods Ltd (Halo) in partnership with the exisiting management team.Headquartered in Newport, Wales (UK), Halo is a leading manufacturer of healthy bars and snacks, with an extensive portfolio that includes cereal bars, fruit and nut bars, gluten-free, high protein and nutritionally controlled bars, including the rapidly growing “Skinny” brand. It has a diverse customer base including national retailers and established international brands. Halo has built an outstanding reputation for providing excellent customer service and exceptional product quality
The nature of Israel’s legal system, the availability of local financing, and expanding numbers of tech-based targets helped the country post its best first-half deal figures in over a decade, according to Pitchbook’s 2020 Israel Private Capital Breakdown report.
The report, which was released today and covers both private equity in Israel as well as the nation’s growing VC ecosystem, shows that 24 transactions closed worth USD 2.9 billion in H1 2020 – a year on year increase of 48.3 per cent and 16.2 per cent, respectively.
Israel’s private equity ecosystem is growing rapidly due to several factors, one of
Questa Capital Management, a venture growth equity firm exclusively dedicated to the healthcare industry, has held the final close of Questa Capital Partners II, with USD348 million of capital commitments. The firm’s second fund will invest selectively in later stage companies in healthcare services, technology and medical devices with significant growth potential. The firm has a proven team with a collective 70 years of experience investing in and building growth stage companies.
The Fund was oversubscribed at its hard cap, securing commitments from a diversified blue-chip investor base comprised of leading endowments, foundations, family offices, consultants, pension plans and fund-of-funds.
Questa
Stirling Square Capital Partners (Stirling Square), a pan-European mid-market private equity firm, has made an additional investment in portfolio company DOCU Nordic Group Holdings AB (DOCU Nordic) in partnership with TA Associates. TA Associates will acquire a significant minority stake in the Company from Stirling Square’s Third Fund alongside Stirling Square’s Fourth Fund, which becomes the majority shareholder in DOCU Nordic.
Headquartered in Ljusdal, Sweden, DOCU Nordic is the leading provider of business intelligence and data analytics services within the construction, real estate and healthcare markets in Scandinavia, Central Europe and Iberia.
During Stirling Square’s Third Fund’s ownership, DOCU Nordic substantially
Fintech company, Growth Capital Ventures (GCV), has secured GBP1 million of growth capital from institutional investors to continue its expansion and fast-track the growth of Britain’s burgeoning tech sector. GCV has now opened up the investment round to new private investors via its online investment platform – growthfunders.com
Investment from the current round will enable GCV to support 30 high-growth start-ups and create hundreds of new tech jobs within the North East through its venture builder unit, G-Labs. It will also enable GCV to increase internal headcount from 22 to 40 in the next 12-24 months.
The funding announcement comes as
Stemson Therapeutics announced today £6 million seed financing from impact investor Fortunis Capital and Allergan Aesthetics, an AbbVie Company, to advance development of Stemson’s therapeutic solution to cure hair loss. Stemson aims to restore human hair growth with a novel approach using the patient’s own cells to generate new hair follicles. Allergan Aesthetics is a world leading medical aesthetics company. Fortunis Capital, a London-based venture capital firm is committed to continuing support of Stemson’s regenerative cell therapy to treat hair loss. Fortunis Capital’s new Impact Fund intends to invest in companies, such as Stemson, which offer significant social or environmental benefit.
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
